New indications and dosing regimens - Xeloda (capecitabine)

Xeloda (capecitabine) - new indications for 1) perioperative treatment of locally advanced rectal cancer, 2) gastric cancer, 3) esophageal cancer, and 4) adjuvant treatment of pancreatic cancer.

Also, new dosing regimens approved for 1) adjuvant treatment of stage III colon cancer, 2) unresectable or metastatic colorectal cancer, and 3) advanced or metastatic breast cancer.